Top Banner
45

The Good, The Bad and The Ugly of Clinical Research Sites.

Dec 27, 2015

Download

Documents

Neal Willis
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: The Good, The Bad and The Ugly of Clinical Research Sites.
Page 2: The Good, The Bad and The Ugly of Clinical Research Sites.

The Good, The Bad and The Ugly

of Clinical Research Sites

Page 3: The Good, The Bad and The Ugly of Clinical Research Sites.

Includes FDA Documents as “Learning Tools”

Form 1572 Warning Letters Notice of Observations (483s) Publications (FDA Consumer) Investigator Lists

– Debarment– Disqualification

Federal Register Notices

AND

Page 4: The Good, The Bad and The Ugly of Clinical Research Sites.

Features Clint Eastwood films

Titles

Phrases

Music

Photos

Page 5: The Good, The Bad and The Ugly of Clinical Research Sites.

Define “Good Clinical Practice” requirements with investigator obligations

Review 3 cases of research misconduct– Read public documents available from FDA– Highlight some “signs and symptoms” of the

misconduct– Examine investigator-study coordinator interactions

“Hang ‘Em High”

Objectives

Page 6: The Good, The Bad and The Ugly of Clinical Research Sites.

Warning! Warning! Warning! Letter1. Dr “Dirty Harry” Bear Investigator

“True Crime(s)”2. The Borison – Diamond Affair

3. Dr. Robert “Every Which Way But Loose” Fiddes

“Make My Day”

Cases

AND

Page 7: The Good, The Bad and The Ugly of Clinical Research Sites.

Music Titles

Pictures Quotes

Film Clues

Page 8: The Good, The Bad and The Ugly of Clinical Research Sites.

Prizes

Correctly guess:

1. Total number of film clues in presentation– 12 clues, so far

2. Total number of unique film clues– 9 clues, so far

Page 9: The Good, The Bad and The Ugly of Clinical Research Sites.

The “Good Clinical Practice” Definition

ICH: “Perfect World” for Clinical Trials

Page 10: The Good, The Bad and The Ugly of Clinical Research Sites.

Good Clinical Practice (GCP)

A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that

the Data and Reported Results are Credible, and Accurate, and that

the Rights, Integrity, and Confidentiality of Trial Subjects are Protected.

= Quality Data

= Ethics

Quality Data + Ethics = GCPs

Page 11: The Good, The Bad and The Ugly of Clinical Research Sites.

Investigator Obligations

FDA Form 1572

“Absolute Power”

Page 12: The Good, The Bad and The Ugly of Clinical Research Sites.

“Read the SMALL PRINT of the 1572” [Investigator Commitments: Box 9]

S _______ M ______ ______ A _____ to _______ L ____ __________ ________ L et FDA Inspect

__P__ _______ _______ R etain Records I _____ _______ N ____ _ _ _ T ____ ______

upervise

aintain Recordsdhere Protocolearn Investigator’s Brochure

Re ort Adverse Events

nform Subjects

otify I R Brain Staff

“Sudden Impact” GCP Document

Page 13: The Good, The Bad and The Ugly of Clinical Research Sites.

How many clues do you have now?

Page 14: The Good, The Bad and The Ugly of Clinical Research Sites.

Harry D. Bear M.D., Ph.D.(Virginia Commonwealth University)

Case #1

Investigator with unqualified coordinators

Page 15: The Good, The Bad and The Ugly of Clinical Research Sites.

“Dirty Harry’s” Warning Letter

A Sep 27, 2002 FDA communication for violations which are regulatory significant and that failure to adequately and promptly make corrections may expect enforcement action by FDA if the violation(s) continue.– FDA as “Enforcer” and Dr Bear as “High Plains

Drifter”– http://www.fda.gov/foi/warning_letters/g3537d.htm

Page 16: The Good, The Bad and The Ugly of Clinical Research Sites.

“Any Which Way You Can”

“People issues” are noted often in the warning letter:– “Not qualified,” “inexperienced,” “unauthorized” – Need to “supervise,” “monitor,” “train”

S M A L L P R I N T

[of the FDA Form 1572]

Page 17: The Good, The Bad and The Ugly of Clinical Research Sites.

“Dirty Harry’s” Warning Letter

S upervise– “It is your responsibility to monitor

all personnel…”– “There are several examples of…

reports that were not signed or dated by you or a subinvestigator responsible to you.”

– “…please explain how you will supervise study staff to ensure…”

– “Your response is therefore inadequate to explain how a different person was granted the authority to…”

T rain staff– “…individuals who have

prepared study drugs have not been registered pharmacists qualified by training and experience…”

– “…visits were conducted by personnel not medically qualified to evaluate the subject’ disease status,…”

– “…attributes these errors to the “initial inexperience” of the person who…”

Page 18: The Good, The Bad and The Ugly of Clinical Research Sites.

Dr. Bear: “High Plains Drifter”

“Several study visits were conducted by personnel not medically qualified to evaluate the subject’s disease status, including the study coordinator…”

“The study coordinator signed the “Request to Transfer Patient” form…even though the “Site Reference Manual” requires that “the investigator must review and sign…”

Page 19: The Good, The Bad and The Ugly of Clinical Research Sites.

: “The Enforcer”

“These errors reflect a pattern of insufficient training and experience that may impact the safety and welfare of subjects, and the ability to determine the safety and efficacy of the study drug.”

ethics data quality

Page 20: The Good, The Bad and The Ugly of Clinical Research Sites.

FDA Timeline for Dr. Bear

Inspection ended 29 Apr 2002

Warning Letter posted 27 Sep 2002

Disqualification process starts? Unknown

Page 21: The Good, The Bad and The Ugly of Clinical Research Sites.

More Clues Ahead!

Page 22: The Good, The Bad and The Ugly of Clinical Research Sites.

Richard Borison M.D. and Bruce Diamond Ph.D

(Medical College of Georgia?)

Case #2

Investigators with “Rookie” Coordinators

Page 23: The Good, The Bad and The Ugly of Clinical Research Sites.

Form FDA 483: Inspectional Observations for Richard L. Borison

Inspection Dates: 06 Nov 1996 – 22 Apr 1997 20 Significant Findings (I.e., 4 pages) Added note: Dr Diamond received a separate

Form FDA 483 with 13 of the exact same findings

Page 24: The Good, The Bad and The Ugly of Clinical Research Sites.

“A Fistful of Dollars”

Wall Street Journal (15 Aug 1997) Headlines– Drug Makers Relied on Clinical Researchers Who

Now Await Trial– Two Professors Are Accused of Endangering

Patients and Stealing $10 Million– ‘Checks and Balances’ Failed

Page 25: The Good, The Bad and The Ugly of Clinical Research Sites.

The “Rookie” Coordinators

“Two of their study coordinators had been hired after working as Girl Scout administrators; another had recently been a Delta Airlines flight attendant.”

Ms. A “who began working … as a study coordinator …, also had no medical training, yet was put to work interpreting electrocardiograms and blood tests.

WSJ: 15 Aug 1997

Page 26: The Good, The Bad and The Ugly of Clinical Research Sites.

The “Rookie” Coordinators

Ms. B “who coordinated Borison-Diamond drug trials at the VA hospital says Dr Diamond pushed her so to hard to recruit and retain subjects for a Sandoz study of a schizophrenia drug that she misled patients – claiming the experimental medicine may be the “next wonder” drug.”

WSJ: 15 Aug 1997

Page 27: The Good, The Bad and The Ugly of Clinical Research Sites.

“For a Few Dollars More”

CBS’ 48 Hours, The Ultimate Risk, aired on 15 Apr 1999– Whistleblower was a study coordinator

Page 28: The Good, The Bad and The Ugly of Clinical Research Sites.

“Thunderbolt and Lightfoot”

Borison Diamond Guilty!

54 36 Felony Counts

150K 125K Fines

$4.26M $1.1M Restitution

15 5 Imprisonment

15 10 Probation

Page 29: The Good, The Bad and The Ugly of Clinical Research Sites.

FDA Timeline for Dr. Borison

Inspection ended 22 Apr 1997

[No warning letter issued]

Prison term started 09 Oct 1998

Disqualified 10 Nov 1998

Debarred (10 yrs) 30 Sep 2003

Page 30: The Good, The Bad and The Ugly of Clinical Research Sites.

Robert Fiddes, M.D.(Southern California Research Institute)

Case #3

Investigator with his “Beguiled” band of Coordinators

Page 31: The Good, The Bad and The Ugly of Clinical Research Sites.

News Article in FDA Consumer

“Physician Sentenced for Doctoring Drug Data” by Tamar Nordenberg

Page 32: The Good, The Bad and The Ugly of Clinical Research Sites.

“For a Few Dollars More”

New York Times (17 May 1999) Headlines

A Doctor’s Drug Trials Turn Into Fraud– “Companies large and small showered him not only

with more than 170 studies to conduct, but with millions of dollars in compensation for his work.”

Page 33: The Good, The Bad and The Ugly of Clinical Research Sites.

Band of “Beguiled” Coordinators

“Few employees other than the study coordinators – mostly women of limited financial means – aware of the magnitude of the swindle.”

“Like every other study coordinator who passed through Dr. Fiddes’s research center, Ms. C found herself being pushed to break the rules.”

NYT: 17 May 1999

Page 34: The Good, The Bad and The Ugly of Clinical Research Sites.

Band of “Beguiled” Coordinators

“Again and again, study coordinators were instructed by Dr. Fiddes and his top aide, Ms. Charpentier, to ignore the requirements of the drug studies.”

“Dr. Fiddes’s coordinators, paid bonuses for recruiting patients into studies, soon began improperly enrolling themselves and members of their families.”

NYT: 17 May 1999

Page 35: The Good, The Bad and The Ugly of Clinical Research Sites.

“Blood Work” Fraud

“Bodily fluids that met certain lab values were kept on hand in the office refrigerator, ready to be substituted for the urine or blood of patients who did not qualify for studies.”

NYT: 17 May 1999

Page 36: The Good, The Bad and The Ugly of Clinical Research Sites.

“In The Line of Fire”

“…Dr Fiddes laid much of the blame for everything that happened on his study coordinators – again, without providing evidence to support the assertion.”

“He told them that fraud was rampant in the research industry. He named names of doctors he suspected of engaging in practices similar to his own.”

NYT: 17 May 1999

Page 37: The Good, The Bad and The Ugly of Clinical Research Sites.

Fiddes: “Unforgiven?”

“But, the investigators asked, …What could the watchdogs have seen that would have allowed them to detect his fraud?

“Nothing, Dr Fiddes replied. ”– “Had it not been for a disgruntled employee, he

would have still been in business.” Disgruntled employee was a study coordinator

NYT: 17 May 1999

Page 38: The Good, The Bad and The Ugly of Clinical Research Sites.

The Final “Gauntlet”

Dr. Fiddes was sentenced to 15 months in prison, ordered to repay $800,000, and debarred.

3 study coordinators were found guilty. One study coordinator was debarred.

Page 39: The Good, The Bad and The Ugly of Clinical Research Sites.

FDA Timeline for Dr. Fiddes

Inspection ended 28 Feb 1996

[No Warning Letter issued]

Pleaded guilty Aug 1997

Sentenced to prison Sep 1998

Disqualified 01 Jun 1999

Debarred (20 yrs) 06 Nov 2002

Page 40: The Good, The Bad and The Ugly of Clinical Research Sites.

FDA Disqualification and Debarment Lists

Disqualification:– http://www.fda.gov/ora/compliance_ref/bimo/disqlist.

htm

Debarment:– http://www.fda.gov/ora/compliance_ref/debar/default

.htm

Page 41: The Good, The Bad and The Ugly of Clinical Research Sites.

Some Final Thoughts

Page 42: The Good, The Bad and The Ugly of Clinical Research Sites.

Final Advice

Conduct “ethical” clinical research Protect the “needs of” and “risks to” patients Generate “quality data” Follow “GCP responsibilities” of the 1572 Seek out more education in “GCPs” Develop strong partnerships between

investigator and study coordinator

Page 43: The Good, The Bad and The Ugly of Clinical Research Sites.

Clint Eastwood Film Clues

Photos– The Outlaw Josey Wales– Dirty Harry– Hang ‘Em High– Space Cowboys – Pink Cadillac– The Bridges of Madison

County– Kelly’s Heroes– Unforgiven (Oscar Night)

Music– The Good, The Bad, and

The Ugly (title theme)– A Perfect World (End

Credits Medley)

Quote– “Make My Day” (Dirty

Harry)

Page 44: The Good, The Bad and The Ugly of Clinical Research Sites.

Clint Eastwood Film Clues (Titles)

The Good, the Bad, and the Ugly

Dirty Harry (2) Hang ‘Em High Paint Your Wagon Absolute Power Sudden Impact

A Perfect World True Crime Every Which Way But

Loose Rookie (3) A Fistful of Dollars For a Few Dollars More

(2)

Page 45: The Good, The Bad and The Ugly of Clinical Research Sites.

Clint Eastwood Film Clues (Titles)

Thunderbolt and Lightfoot

Enforcer (2) High Plains Drifter (2) Any Which Way You

Can

Beguiled (3) Blood Work In the Line of Fire Unforgiven Gauntlet